NeuroDerm to Ring the Nasdaq Stock Market Opening Bell and Participate in the Parkinson’s Unity Walk

(April 20, 2017) – NeuroDerm, a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that the company’s CEO, Oded S. Lieberman, PhD, will ring The Nasdaq Stock Market Opening Bell in New York on Friday, April 21, 2017. They will also participate in the Parkinson’s Unity Walk on April 23, 2017. Read more…